Status:
COMPLETED
High-dose L-Carnitine and Diaphragmatic Function Assessed by Ultrasonography in Patients With Respiratory Failure.
Lead Sponsor:
Ain Shams University
Conditions:
Respiratory Failure
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
L-Carnitine supplementation has been shown to boost muscular performance in several studies. In hemodialysis patients with muscular weakness, fatigue, or cramps/aches, after L-carnitine treatment, abo...
Eligibility Criteria
Inclusion
- Age from 21 years old or greater
- Both genders have respiratory failure either of the primary medical origin or in the post-surgical course.
- Not in need of mechanical ventilation
Exclusion
- Renal failure on regular dialysis
- Hypothyroidism
- Seizures
- End-stage liver disease
- Mechanical ventilation
- History or discovered allergy to L-carnitine, pivampicillin, and other pivalate-conjugated antibiotics.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05322447
Start Date
April 15 2022
End Date
October 1 2022
Last Update
October 17 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine
Cairo, Egypt, 1234
2
Mona A Ammar
Cairo, Egypt